Global and Japan Biosimilar Insulin Market Insights, Forecast to 2027

Global and Japan Biosimilar Insulin Market Insights, Forecast to 2027

Table of Contents
1 Study Coverage
1.1 Biosimilar Insulin Product Introduction
1.2 Market by Type
1.2.1 Global Biosimilar Insulin Market Size Growth Rate by Type
1.2.2 Rapid Acting Insulins
1.2.3 Short Acting Insulins
1.2.4 Intermediate Insulins
1.2.5 Long Lasting Insulins
1.3 Market by Application
1.3.1 Global Biosimilar Insulin Market Size Growth Rate by Application
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Medical Center
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Biosimilar Insulin Market Size, Estimates and Forecasts
2.1.1 Global Biosimilar Insulin Revenue 2016-2027
2.1.2 Global Biosimilar Insulin Sales 2016-2027
2.2 Global Biosimilar Insulin, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Biosimilar Insulin Historical Market Size by Region (2016-2021)
2.3.1 Global Biosimilar Insulin Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Biosimilar Insulin Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Biosimilar Insulin Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Biosimilar Insulin Sales Forecast by Region (2022-2027)
2.4.2 Global Biosimilar Insulin Revenue Forecast by Region (2022-2027)
3 Global Biosimilar Insulin Competitor Landscape by Players
3.1 Global Top Biosimilar Insulin Manufacturers by Sales
3.1.1 Global Biosimilar Insulin Sales by Manufacturer (2016-2021)
3.1.2 Global Biosimilar Insulin Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Biosimilar Insulin Manufacturers by Revenue
3.2.1 Key Biosimilar Insulin Manufacturers Covered: Ranking by Revenue
3.2.2 Global Biosimilar Insulin Revenue by Manufacturers (2016-2021)
3.2.3 Global Biosimilar Insulin Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Biosimilar Insulin Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Biosimilar Insulin Revenue in 2020
3.2.6 Global Biosimilar Insulin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Biosimilar Insulin Price by Manufacturers
3.4 Global Biosimilar Insulin Manufacturing Base Distribution, Product Types
3.4.1 Biosimilar Insulin Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Biosimilar Insulin Product Type
3.4.3 Date of International Manufacturers Enter into Biosimilar Insulin Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Biosimilar Insulin Market Size by Type (2016-2021)
4.1.1 Global Biosimilar Insulin Sales by Type (2016-2021)
4.1.2 Global Biosimilar Insulin Revenue by Type (2016-2021)
4.1.3 Biosimilar Insulin Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Biosimilar Insulin Market Size Forecast by Type (2022-2027)
4.2.1 Global Biosimilar Insulin Sales Forecast by Type (2022-2027)
4.2.2 Global Biosimilar Insulin Revenue Forecast by Type (2022-2027)
4.2.3 Biosimilar Insulin Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Biosimilar Insulin Market Size by Application (2016-2021)
5.1.1 Global Biosimilar Insulin Sales by Application (2016-2021)
5.1.2 Global Biosimilar Insulin Revenue by Application (2016-2021)
5.1.3 Biosimilar Insulin Price by Application (2016-2021)
5.2 Biosimilar Insulin Market Size Forecast by Application (2022-2027)
5.2.1 Global Biosimilar Insulin Sales Forecast by Application (2022-2027)
5.2.2 Global Biosimilar Insulin Revenue Forecast by Application (2022-2027)
5.2.3 Global Biosimilar Insulin Price Forecast by Application (2022-2027)
6 Japan by Players, Type and Application
6.1 Japan Biosimilar Insulin Market Size YoY Growth 2016-2027
6.1.1 Japan Biosimilar Insulin Sales YoY Growth 2016-2027
6.1.2 Japan Biosimilar Insulin Revenue YoY Growth 2016-2027
6.1.3 Japan Biosimilar Insulin Market Share in Global Market 2016-2027
6.2 Japan Biosimilar Insulin Market Size by Players (International and Local Players)
6.2.1 Japan Top Biosimilar Insulin Players by Sales (2016-2021)
6.2.2 Japan Top Biosimilar Insulin Players by Revenue (2016-2021)
6.3 Japan Biosimilar Insulin Historic Market Review by Type (2016-2021)
6.3.1 Japan Biosimilar Insulin Sales Market Share by Type (2016-2021)
6.3.2 Japan Biosimilar Insulin Revenue Market Share by Type (2016-2021)
6.3.3 Japan Biosimilar Insulin Price by Type (2016-2021)
6.4 Japan Biosimilar Insulin Market Estimates and Forecasts by Type (2022-2027)
6.4.1 Japan Biosimilar Insulin Sales Forecast by Type (2022-2027)
6.4.2 Japan Biosimilar Insulin Revenue Forecast by Type (2022-2027)
6.4.3 Japan Biosimilar Insulin Price Forecast by Type (2022-2027)
6.5 Japan Biosimilar Insulin Historic Market Review by Application (2016-2021)
6.5.1 Japan Biosimilar Insulin Sales Market Share by Application (2016-2021)
6.5.2 Japan Biosimilar Insulin Revenue Market Share by Application (2016-2021)
6.5.3 Japan Biosimilar Insulin Price by Application (2016-2021)
6.6 Japan Biosimilar Insulin Market Estimates and Forecasts by Application (2022-2027)
6.6.1 Japan Biosimilar Insulin Sales Forecast by Application (2022-2027)
6.6.2 Japan Biosimilar Insulin Revenue Forecast by Application (2022-2027)
6.6.3 Japan Biosimilar Insulin Price Forecast by Application (2022-2027)
7 North America
7.1 North America Biosimilar Insulin Market Size YoY Growth 2016-2027
7.2 North America Biosimilar Insulin Market Facts & Figures by Country
7.2.1 North America Biosimilar Insulin Sales by Country (2016-2021)
7.2.2 North America Biosimilar Insulin Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Biosimilar Insulin Market Size YoY Growth 2016-2027
8.2 Asia Pacific Biosimilar Insulin Market Facts & Figures by Region
8.2.1 Asia Pacific Biosimilar Insulin Sales by Region (2016-2021)
8.2.2 Asia Pacific Biosimilar Insulin Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam
9 Europe
9.1 Europe Biosimilar Insulin Market Size YoY Growth 2016-2027
9.2 Europe Biosimilar Insulin Market Facts & Figures by Country
9.2.1 Europe Biosimilar Insulin Sales by Country (2016-2021)
9.2.2 Europe Biosimilar Insulin Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Biosimilar Insulin Market Size YoY Growth 2016-2027
10.2 Latin America Biosimilar Insulin Market Facts & Figures by Country
10.2.1 Latin America Biosimilar Insulin Sales by Country (2016-2021)
10.2.2 Latin America Biosimilar Insulin Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Biosimilar Insulin Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Biosimilar Insulin Market Facts & Figures by Country
11.2.1 Middle East and Africa Biosimilar Insulin Sales by Country (2016-2021)
11.2.2 Middle East and Africa Biosimilar Insulin Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Pfizer
12.1.1 Pfizer Corporation Information
12.1.2 Pfizer Description and Business Overview
12.1.3 Pfizer Biosimilar Insulin Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Pfizer Biosimilar Insulin Products Offered
12.1.5 Pfizer Recent Development
12.2 Biogenomics
12.2.1 Biogenomics Corporation Information
12.2.2 Biogenomics Description and Business Overview
12.2.3 Biogenomics Biosimilar Insulin Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Biogenomics Biosimilar Insulin Products Offered
12.2.5 Biogenomics Recent Development
12.3 Eli Lilly
12.3.1 Eli Lilly Corporation Information
12.3.2 Eli Lilly Description and Business Overview
12.3.3 Eli Lilly Biosimilar Insulin Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Eli Lilly Biosimilar Insulin Products Offered
12.3.5 Eli Lilly Recent Development
12.4 Gan&Lee Pharmaceuticals
12.4.1 Gan&Lee Pharmaceuticals Corporation Information
12.4.2 Gan&Lee Pharmaceuticals Description and Business Overview
12.4.3 Gan&Lee Pharmaceuticals Biosimilar Insulin Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Gan&Lee Pharmaceuticals Biosimilar Insulin Products Offered
12.4.5 Gan&Lee Pharmaceuticals Recent Development
12.5 Geropharm
12.5.1 Geropharm Corporation Information
12.5.2 Geropharm Description and Business Overview
12.5.3 Geropharm Biosimilar Insulin Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Geropharm Biosimilar Insulin Products Offered
12.5.5 Geropharm Recent Development
12.6 Julphar Gulf Pharmaceutical Industries
12.6.1 Julphar Gulf Pharmaceutical Industries Corporation Information
12.6.2 Julphar Gulf Pharmaceutical Industries Description and Business Overview
12.6.3 Julphar Gulf Pharmaceutical Industries Biosimilar Insulin Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Julphar Gulf Pharmaceutical Industries Biosimilar Insulin Products Offered
12.6.5 Julphar Gulf Pharmaceutical Industries Recent Development
12.7 Paras Biopharmaceuticals
12.7.1 Paras Biopharmaceuticals Corporation Information
12.7.2 Paras Biopharmaceuticals Description and Business Overview
12.7.3 Paras Biopharmaceuticals Biosimilar Insulin Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Paras Biopharmaceuticals Biosimilar Insulin Products Offered
12.7.5 Paras Biopharmaceuticals Recent Development
12.8 Samsung Bioepis
12.8.1 Samsung Bioepis Corporation Information
12.8.2 Samsung Bioepis Description and Business Overview
12.8.3 Samsung Bioepis Biosimilar Insulin Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Samsung Bioepis Biosimilar Insulin Products Offered
12.8.5 Samsung Bioepis Recent Development
12.9 Sedico
12.9.1 Sedico Corporation Information
12.9.2 Sedico Description and Business Overview
12.9.3 Sedico Biosimilar Insulin Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Sedico Biosimilar Insulin Products Offered
12.9.5 Sedico Recent Development
12.10 Wockhardt
12.10.1 Wockhardt Corporation Information
12.10.2 Wockhardt Description and Business Overview
12.10.3 Wockhardt Biosimilar Insulin Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Wockhardt Biosimilar Insulin Products Offered
12.10.5 Wockhardt Recent Development
12.11 Pfizer
12.11.1 Pfizer Corporation Information
12.11.2 Pfizer Description and Business Overview
12.11.3 Pfizer Biosimilar Insulin Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Pfizer Biosimilar Insulin Products Offered
12.11.5 Pfizer Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Biosimilar Insulin Industry Trends
13.2 Biosimilar Insulin Market Drivers
13.3 Biosimilar Insulin Market Challenges
13.4 Biosimilar Insulin Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Biosimilar Insulin Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Global Biosimilar Insulin Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Rapid Acting Insulins
Table 3. Major Manufacturers of Short Acting Insulins
Table 4. Major Manufacturers of Intermediate Insulins
Table 5. Major Manufacturers of Long Lasting Insulins
Table 6. Global Biosimilar Insulin Market Size Growth Rate by Application (2021-2027) & (K Pcs)
Table 7. Global Biosimilar Insulin Market Size by Region (K Pcs) & (US$ Million), 2016 VS 2021 VS 2027
Table 8. Global Biosimilar Insulin Sales by Regions (2016-2021) & (K Pcs)
Table 9. Global Biosimilar Insulin Sales Market Share by Regions (2016-2021)
Table 10. Global Biosimilar Insulin Revenue by Regions (2016-2021) & (US$ Million)
Table 11. Global Biosimilar Insulin Sales Forecast by Region (2022-2027) & (K Pcs)
Table 12. Global Biosimilar Insulin Sales Market Share Forecast by Region (2022-2027)
Table 13. Global Biosimilar Insulin Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 14. Global Biosimilar Insulin Revenue Market Share Forecast by Region (2022-2027)
Table 15. Global Biosimilar Insulin Sales by Manufacturers (2016-2021) (K Pcs)
Table 16. Global Biosimilar Insulin Sales Share by Manufacturers (2016-2021)
Table 17. Ranking of Global Top Biosimilar Insulin Manufacturers by Revenue (US$ Million) in 2020
Table 18. Biosimilar Insulin Revenue by Manufacturers (2016-2021) (US$ Million)
Table 19. Biosimilar Insulin Revenue Share by Manufacturers (2016-2021)
Table 20. Global Biosimilar Insulin Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 21. Global Biosimilar Insulin by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biosimilar Insulin as of 2020)
Table 22. Key Manufacturers Biosimilar Insulin Price (2016-2021) (USD/Pcs)
Table 23. Biosimilar Insulin Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Biosimilar Insulin Product Type
Table 25. Date of International Manufacturers Enter into Biosimilar Insulin Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Biosimilar Insulin Sales by Type (2016-2021) (K Pcs)
Table 28. Global Biosimilar Insulin Sales Share by Type (2016-2021)
Table 29. Global Biosimilar Insulin Revenue by Type (2016-2021) (US$ Million)
Table 30. Global Biosimilar Insulin Revenue Share by Type (2016-2021)
Table 31. Biosimilar Insulin Average Selling Price (ASP) by Type (2016-2021) & (USD/Pcs)
Table 32. Global Biosimilar Insulin Sales Forecast by Type (2022-2027) & (K Pcs)
Table 33. Global Biosimilar Insulin Sales Market Share Forecast by Type (2022-2027)
Table 34. Global Biosimilar Insulin Revenue Forecast V (2022-2027) & (US$ Million)
Table 35. Global Biosimilar Insulin Revenue Market Share Forecast by Type (2022-2027)
Table 36. Global Biosimilar Insulin Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/Pcs)
Table 37. Global Biosimilar Insulin Sales by Application (2016-2021) (K Pcs)
Table 38. Global Biosimilar Insulin Sales Share by Application (2016-2021)
Table 39. Global Biosimilar Insulin Revenue by Application (2016-2021) (US$ Million)
Table 40. Global Biosimilar Insulin Revenue Share by Application (2016-2021)
Table 41. Biosimilar Insulin Average Selling Price (ASP) by Application (2016-2021) & (USD/Pcs)
Table 42. Global Biosimilar Insulin Sales Forecast by Application (2022-2027) & (K Pcs)
Table 43. Global Biosimilar Insulin Sales Market Share Forecast by Application (2022-2027)
Table 44. Global Biosimilar Insulin Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 45. Global Biosimilar Insulin Revenue Market Share Forecast by Application (2022-2027)
Table 46. Global Biosimilar Insulin Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/Pcs)
Table 47. Japan Biosimilar Insulin Sales (K Pcs) of Key Companies (2016-2021)
Table 48. Japan Biosimilar Insulin Sales Share by Company (2016-2021)
Table 49. Japan Biosimilar Insulin Revenue (US$ Million) by Company (2016-2021)
Table 50. Japan Biosimilar Insulin Revenue Share by Company (2016-2021)
Table 51. Japan Biosimilar Insulin Sales (K Pcs) by Type (2016-2021)
Table 52. Japan Biosimilar Insulin Sales Share by Type (2016-2021)
Table 53. Japan Biosimilar Insulin Revenue (US$ Million) Market Share by Type (2016-2021)
Table 54. Japan Biosimilar Insulin Price (USD/Pcs) by Type (2016-2021)
Table 55. Japan Biosimilar Insulin Sales (K Pcs) by Type (2022-2027)
Table 56. Japan Biosimilar Insulin Sales Share by Type (2022-2027)
Table 57. Japan Biosimilar Insulin Revenue (US$ Million) Market Share by Type (2022-2027)
Table 58. Japan Biosimilar Insulin Revenue Share by Type (2022-2027)
Table 59. Japan Biosimilar Insulin Price (USD/Pcs) by Type (2022-2027)
Table 60. Japan Biosimilar Insulin Sales (K Pcs) by Application (2016-2021)
Table 61. Japan Biosimilar Insulin Sales Share by Application (2016-2021)
Table 62. Japan Biosimilar Insulin Revenue (US$ Million) Market Share by Application (2016-2021)
Table 63. Japan Biosimilar Insulin Price (USD/Pcs) by Application (2016-2021)
Table 64. Japan Biosimilar Insulin Sales (K Pcs) by Application (2022-2027)
Table 65. Japan Biosimilar Insulin Sales Share by Application (2022-2027)
Table 66. Japan Biosimilar Insulin Revenue (US$ Million) Market Share by Application (2022-2027)
Table 67. Japan Biosimilar Insulin Revenue Share by Application (2022-2027)
Table 68. Japan Biosimilar Insulin Price (USD/Pcs) by Application (2022-2027)
Table 69. North America Biosimilar Insulin Sales by Country (2016-2021) & (K Pcs)
Table 70. North America Biosimilar Insulin Sales Market Share by Country (2016-2021)
Table 71. North America Biosimilar Insulin Revenue by Country (2016-2021) & (US$ Million)
Table 72. North America Biosimilar Insulin Revenue Market Share by Country (2016-2021)
Table 73. Asia Pacific Biosimilar Insulin Sales by Region (2016-2021) & (K Pcs)
Table 74. Asia Pacific Biosimilar Insulin Sales Market Share by Region (2016-2021)
Table 75. Asia Pacific Biosimilar Insulin Revenue by Region (2016-2021) & (US$ Million)
Table 76. Asia Pacific Biosimilar Insulin Revenue Market Share by Region (2016-2021)
Table 77. Europe Biosimilar Insulin Sales by Country (2016-2021) & (K Pcs)
Table 78. Europe Biosimilar Insulin Sales Market Share by Country (2016-2021)
Table 79. Europe Biosimilar Insulin Revenue by Country (2016-2021) & (US$ Million)
Table 80. Europe Biosimilar Insulin Revenue Market Share by Country (2016-2021)
Table 81. Latin America Biosimilar Insulin Sales by Country (2016-2021) & (K Pcs)
Table 82. Latin America Biosimilar Insulin Sales Market Share by Country (2016-2021)
Table 83. Latin Americaa Biosimilar Insulin Revenue by Country (2016-2021) & (US$ Million)
Table 84. Latin America Biosimilar Insulin Revenue Market Share by Country (2016-2021)
Table 85. Middle East and Africa Biosimilar Insulin Sales by Country (2016-2021) & (K Pcs)
Table 86. Middle East and Africa Biosimilar Insulin Sales Market Share by Country (2016-2021)
Table 87. Middle East and Africa Biosimilar Insulin Revenue by Country (2016-2021) & (US$ Million)
Table 88. Middle East and Africa Biosimilar Insulin Revenue Market Share by Country (2016-2021)
Table 89. Pfizer Corporation Information
Table 90. Pfizer Description and Business Overview
Table 91. Pfizer Biosimilar Insulin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 92. Pfizer Biosimilar Insulin Product
Table 93. Pfizer Recent Development
Table 94. Biogenomics Corporation Information
Table 95. Biogenomics Description and Business Overview
Table 96. Biogenomics Biosimilar Insulin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 97. Biogenomics Product
Table 98. Biogenomics Recent Development
Table 99. Eli Lilly Corporation Information
Table 100. Eli Lilly Description and Business Overview
Table 101. Eli Lilly Biosimilar Insulin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 102. Eli Lilly Product
Table 103. Eli Lilly Recent Development
Table 104. Gan&Lee Pharmaceuticals Corporation Information
Table 105. Gan&Lee Pharmaceuticals Description and Business Overview
Table 106. Gan&Lee Pharmaceuticals Biosimilar Insulin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 107. Gan&Lee Pharmaceuticals Product
Table 108. Gan&Lee Pharmaceuticals Recent Development
Table 109. Geropharm Corporation Information
Table 110. Geropharm Description and Business Overview
Table 111. Geropharm Biosimilar Insulin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 112. Geropharm Product
Table 113. Geropharm Recent Development
Table 114. Julphar Gulf Pharmaceutical Industries Corporation Information
Table 115. Julphar Gulf Pharmaceutical Industries Description and Business Overview
Table 116. Julphar Gulf Pharmaceutical Industries Biosimilar Insulin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 117. Julphar Gulf Pharmaceutical Industries Product
Table 118. Julphar Gulf Pharmaceutical Industries Recent Development
Table 119. Paras Biopharmaceuticals Corporation Information
Table 120. Paras Biopharmaceuticals Description and Business Overview
Table 121. Paras Biopharmaceuticals Biosimilar Insulin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 122. Paras Biopharmaceuticals Product
Table 123. Paras Biopharmaceuticals Recent Development
Table 124. Samsung Bioepis Corporation Information
Table 125. Samsung Bioepis Description and Business Overview
Table 126. Samsung Bioepis Biosimilar Insulin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 127. Samsung Bioepis Product
Table 128. Samsung Bioepis Recent Development
Table 129. Sedico Corporation Information
Table 130. Sedico Description and Business Overview
Table 131. Sedico Biosimilar Insulin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 132. Sedico Product
Table 133. Sedico Recent Development
Table 134. Wockhardt Corporation Information
Table 135. Wockhardt Description and Business Overview
Table 136. Wockhardt Biosimilar Insulin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 137. Wockhardt Product
Table 138. Wockhardt Recent Development
Table 139. Teva Pharmaceuticals Corporation Information
Table 140. Teva Pharmaceuticals Description and Business Overview
Table 141. Teva Pharmaceuticals Biosimilar Insulin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 142. Teva Pharmaceuticals Product
Table 143. Teva Pharmaceuticals Recent Development
Table 144. Biosimilar Insulin Market Trends
Table 145. Biosimilar Insulin Market Drivers
Table 146. Biosimilar Insulin Market Challenges
Table 147. Biosimilar Insulin Market Restraints
Table 148. Biosimilar Insulin Customers List
Table 149. Biosimilar Insulin Distributors List
Table 150. Research Programs/Design for This Report
Table 151. Key Data Information from Secondary Sources
Table 152. Key Data Information from Primary Sources
List of Figures
Figure 1. Biosimilar Insulin Product Picture
Figure 2. Global Biosimilar Insulin Sales Market Share by Type in 2020 & 2027
Figure 3. Rapid Acting Insulins Product Picture
Figure 4. Short Acting Insulins Product Picture
Figure 5. Intermediate Insulins Product Picture
Figure 6. Long Lasting Insulins Product Picture
Figure 7. Global Biosimilar Insulin Sales Market Share by Application in 2020 & 2027
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Medical Center
Figure 11. Biosimilar Insulin Report Years Considered
Figure 12. Global Biosimilar Insulin Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Biosimilar Insulin Market Size 2016-2027 (US$ Million)
Figure 14. Global Biosimilar Insulin Sales 2016-2027 (K Pcs)
Figure 15. Global Biosimilar Insulin Market Size Market Share by Region: 2021 Versus 2027
Figure 16. Global Biosimilar Insulin Sales Market Share by Region (2016-2021)
Figure 17. Global Biosimilar Insulin Sales Market Share by Region in 2020
Figure 18. Global Biosimilar Insulin Revenue Market Share by Region (2016-2021)
Figure 19. Global Biosimilar Insulin Revenue Market Share by Region in 2020
Figure 20. Global Biosimilar Insulin Sales Share by Manufacturer in 2020
Figure 21. The Top 10 and 5 Players Market Share by Biosimilar Insulin Revenue in 2020
Figure 22. Biosimilar Insulin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 23. Global Biosimilar Insulin Sales Market Share by Type (2016-2021)
Figure 24. Global Biosimilar Insulin Sales Market Share by Type in 2020
Figure 25. Global Biosimilar Insulin Revenue Market Share by Type (2016-2021)
Figure 26. Global Biosimilar Insulin Revenue Market Share by Type in 2020
Figure 27. Global Biosimilar Insulin Sales Market Share by Application (2016-2021)
Figure 28. Global Biosimilar Insulin Sales Market Share by Application in 2020
Figure 29. Global Biosimilar Insulin Revenue Market Share by Application (2016-2021)
Figure 30. Global Biosimilar Insulin Revenue Market Share by Application in 2020
Figure 31. Japan Biosimilar Insulin Sales Growth Rate 2016-2027 (K Pcs)
Figure 32. Japan Biosimilar Insulin Revenue Growth Rate 2016-2027 (US$ Million)
Figure 33. Japan Biosimilar Insulin Market Share in Global Market 2016-2027
Figure 34. Japan 5 and 10 Largest Biosimilar Insulin Players Market Share by Revenue in Biosimilar Insulin in 2020
Figure 35. Japan Biosimilar Insulin Revenue Share by Type (2016-2021)
Figure 36. Japan Biosimilar Insulin Revenue Growth Rate by Type in 2016 & 2020
Figure 37. Japan Biosimilar Insulin Revenue Share by Application (2016-2021)
Figure 38. Japan Biosimilar Insulin Revenue Growth Rate by Application in 2016 & 2020
Figure 39. North America Biosimilar Insulin Sales Growth Rate 2016-2021 (K Pcs)
Figure 40. North America Biosimilar Insulin Revenue Growth Rate 2016-2021 (US$ Million)
Figure 41. North America Biosimilar Insulin Sales Market Share by Country in 2020
Figure 42. North America Biosimilar Insulin Revenue Market Share by Country in 2020
Figure 43. U.S. Biosimilar Insulin Sales Growth Rate (2016-2021) (K Pcs)
Figure 44. U.S. Biosimilar Insulin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Canada Biosimilar Insulin Sales Growth Rate (2016-2021) (K Pcs)
Figure 46. Canada Biosimilar Insulin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Europe Biosimilar Insulin Sales Growth Rate 2016-2021 (K Pcs)
Figure 48. Europe Biosimilar Insulin Revenue Growth Rate 2016-2021 (US$ Million)
Figure 49. Europe Biosimilar Insulin Sales Market Share by Country in 2020
Figure 50. Europe Biosimilar Insulin Revenue Market Share by Country in 2020
Figure 51. Germany Biosimilar Insulin Sales Growth Rate (2016-2021) (K Pcs)
Figure 52. Germany Biosimilar Insulin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 53. France Biosimilar Insulin Sales Growth Rate (2016-2021) (K Pcs)
Figure 54. France Biosimilar Insulin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 55. U.K. Biosimilar Insulin Sales Growth Rate (2016-2021) (K Pcs)
Figure 56. U.K. Biosimilar Insulin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 57. Italy Biosimilar Insulin Sales Growth Rate (2016-2021) (K Pcs)
Figure 58. Italy Biosimilar Insulin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 59. Russia Biosimilar Insulin Sales Growth Rate (2016-2021) (K Pcs)
Figure 60. Russia Biosimilar Insulin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 61. Asia Pacific Biosimilar Insulin Sales Growth Rate 2016-2021 (K Pcs)
Figure 62. Asia Pacific Biosimilar Insulin Revenue Growth Rate 2016-2021 (US$ Million)
Figure 63. Asia Pacific Biosimilar Insulin Sales Market Share by Region in 2020
Figure 64. Asia Pacific Biosimilar Insulin Revenue Market Share by Region in 2020
Figure 65. China Biosimilar Insulin Sales Growth Rate (2016-2021) (K Pcs)
Figure 66. China Biosimilar Insulin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 67. Japan Biosimilar Insulin Sales Growth Rate (2016-2021) (K Pcs)
Figure 68. Japan Biosimilar Insulin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 69. South Korea Biosimilar Insulin Sales Growth Rate (2016-2021) (K Pcs)
Figure 70. South Korea Biosimilar Insulin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 71. India Biosimilar Insulin Sales Growth Rate (2016-2021) (K Pcs)
Figure 72. India Biosimilar Insulin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 73. Australia Biosimilar Insulin Sales Growth Rate (2016-2021) (K Pcs)
Figure 74. Australia Biosimilar Insulin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 75. Taiwan Biosimilar Insulin Sales Growth Rate (2016-2021) (K Pcs)
Figure 76. Taiwan Biosimilar Insulin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 77. Indonesia Biosimilar Insulin Sales Growth Rate (2016-2021) (K Pcs)
Figure 78. Indonesia Biosimilar Insulin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 79. Thailand Biosimilar Insulin Sales Growth Rate (2016-2021) (K Pcs)
Figure 80. Thailand Biosimilar Insulin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 81. Malaysia Biosimilar Insulin Sales Growth Rate (2016-2021) (K Pcs)
Figure 82. Malaysia Biosimilar Insulin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 83. Philippines Biosimilar Insulin Sales Growth Rate (2016-2021) (K Pcs)
Figure 84. Philippines Biosimilar Insulin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 85. Vietnam Biosimilar Insulin Sales Growth Rate (2016-2021) (K Pcs)
Figure 86. Vietnam Biosimilar Insulin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 87. Latin America Biosimilar Insulin Sales Growth Rate 2016-2021 (K Pcs)
Figure 88. Latin America Biosimilar Insulin Revenue Growth Rate 2016-2021 (US$ Million)
Figure 89. Latin America Biosimilar Insulin Sales Market Share by Country in 2020
Figure 90. Latin America Biosimilar Insulin Revenue Market Share by Country in 2020
Figure 91. Mexico Biosimilar Insulin Sales Growth Rate (2016-2021) (K Pcs)
Figure 92. Mexico Biosimilar Insulin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 93. Brazil Biosimilar Insulin Sales Growth Rate (2016-2021) (K Pcs)
Figure 94. Brazil Biosimilar Insulin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 95. Argentina Biosimilar Insulin Sales Growth Rate (2016-2021) (K Pcs)
Figure 96. Argentina Biosimilar Insulin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 97. Middle East and Africa Biosimilar Insulin Sales Growth Rate 2016-2021 (K Pcs)
Figure 98. Middle East and Africa Biosimilar Insulin Revenue Growth Rate 2016-2021 (US$ Million)
Figure 99. Middle East and Africa

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs